• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025

    1/20/26 8:00:00 AM ET
    $EMIS
    $NCRA
    $SOUL
    $STEX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $EMIS alert in real time by email

    NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference Carmel LLP ("SRFC") reported that in 2025 it advised on over 170 announced transactions, with the total value of these transactions exceeding $14 billion, far surpassing the firm's strong performance in 2024. The transactions, on behalf of various market participants, such as issuers, underwriters and investors, included initial public offerings, secondary public offerings, registered direct offerings, private placements, mergers, acquisitions and cryptocurrency transactions.

    In October of 2025, for the fifth consecutive quarter, SRFC was ranked first in the nation for issuer counsel among securities law firms in PlacementTracker's PIPE and Private Placement Markets League Tables for Q3 2025.

    Notable transaction highlights from 2025 include the following representations:

    • Soulpower Acquisition Corporation (NYSE:SOUL) in a definitive business combination agreement with SWB LLC, valued at approximately $8.1 billion.



    • Streamex Corp. (formerly BioSig Technologies, Inc.) (NASDAQ:STEX) in its $1.1 billion growth financing arrangements.



    • Sharps Technology, Inc. (NASDAQ:STSS, STSSW)) in a $400 million private placement.



    • Nocera, Inc. (NASDAQ:NCRA) in a private placement of up to $300 million.



    • Emmis Acquisition Corp. (NASDAQ:EMIS, EMISR)) in its $100 million SPAC initial public offering.



    "The incredible results of our firm's work this past year impresses but doesn't surprise me or any other attorney on this team. Each year, SRFC grows and expands its client base by providing exemplary services and doing right by our clients. It's only natural that more and more companies would take notice of our results and want to retain us as well," said Gregory Sichenzia, founding partner at SRFC. "Prominent entrepreneurs and business leaders want their legal needs handled by the industry's best, and when it comes to complex securities transactions, there's no one better than SRFC. I expect our team to build upon this incredible momentum in 2026."

    "Our firm has been building to this level of success for a while now, as our growing team of talented attorneys have advised on transactions of all kinds across a vast spectrum of industries," said Ross Carmel, named partner at SRFC. "We want to thank our clients, partners and colleagues for an incredible year in 2025 and cannot wait to see continued success throughout this year."

    A full list of the firm's transactions can be found here.

    About Sichenzia Ross Ference Carmel LLP

    SRFC is a nationally recognized law firm of approximately 70 attorneys with corporate, securities, litigation, trusts and estates and tax practices, serving clients from all over the world. Our mission is to solve our clients' most complicated legal problems and achieve their business goals in an expeditious, commercial and innovative manner.

    www.srfc.law

    Media Contact:

    srfc@fischtankpr.com

    This press release may constitute attorney advertising. Prior results do not guarantee a similar outcome. The information in this press release is for general informational purposes only and should not be construed as legal advice or a substitute for obtaining legal advice from an attorney.



    Primary Logo

    Get the next $EMIS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EMIS
    $NCRA
    $SOUL
    $STEX

    CompanyDatePrice TargetRatingAnalyst
    Streamex Corp.
    $STEX
    11/25/2025$12.00Buy
    Needham
    More analyst ratings

    $EMIS
    $NCRA
    $SOUL
    $STEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the third yield payment for GLDY, its gold-backed, yield-bearing tokenized security, occurred on June 18th, 2026. The distribution covers the period from May 1st through May 31st, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is curren

    6/22/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nocera Highlights CampaignPulse.ai Platform Capabilities and Expanding AI Intelligence Opportunity Following Strategic Investment

    Follow-Up Announcement Highlights CampaignPulse.ai's Planned AI-Powered Campaign Intelligence Platform While Nocera Advances Integration of IRMA AI Technologies Through Its Pending Digital Innovations Group Partnership TAIPEI, Taiwan, June 18, 2026 (GLOBE NEWSWIRE) -- via IBN -- Nocera, Inc. (Nasdaq:NCRA) ("Nocera" or the "Company"), which recently announced its strategic transformation into Nocera Holdings and expansion into artificial intelligence, data centers, robotics, biotech and digital assets, today provided additional information regarding its recently announced minority equity investment in CampaignPulse.ai and the platform's planned AI-powered campaign intelligence capabilities

    6/18/26 8:15:00 AM ET
    $NCRA
    Farming/Seeds/Milling
    Consumer Staples

    Nocera Announces Strategic Investment in CampaignPulse.ai, Expanding Artificial Intelligence Portfolio and Advancing Nocera Holdings Growth Strategy

    TAIPEI, Taiwan, June 16, 2026 (GLOBE NEWSWIRE) -- via IBN -- Nocera, Inc. (Nasdaq:NCRA) ("Nocera" or the "Company") today announced that it has acquired a minority equity stake in CampaignPulse.ai, an emerging artificial intelligence company developing simulation-driven campaign intelligence, predictive analytics, and decision-support technologies designed to help organizations improve strategic planning, communications effectiveness, and resource allocation. The investment represents another step in Nocera's recently announced transformation into Nocera Holdings, a diversified technology-focused platform pursuing opportunities across artificial intelligence, digital infrastructure, robot

    6/16/26 8:15:00 AM ET
    $NCRA
    Farming/Seeds/Milling
    Consumer Staples

    $EMIS
    $NCRA
    $SOUL
    $STEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Streamex Exchange Corporation with a new price target

    Needham initiated coverage of Streamex Exchange Corporation with a rating of Buy and set a new price target of $12.00

    11/25/25 7:59:34 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $EMIS
    $NCRA
    $SOUL
    $STEX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    6/15/26 1:21:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:43:32 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,980 worth of shares (34,000 units at $1.47) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/28/26 2:33:28 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $EMIS
    $NCRA
    $SOUL
    $STEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    6/15/26 1:21:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Levine Arthur

    3 - SkyAI, Inc. (0001737995) (Issuer)

    6/3/26 4:30:48 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Investment Officer Williams Mitchell Young sold $24,915 worth of shares (23,810 units at $1.05), decreasing direct ownership by 0.78% to 3,013,838 units (SEC Form 4) to satisfy withholding obligation

    4 - Streamex Corp. (0001530766) (Issuer)

    6/2/26 9:54:16 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $EMIS
    $NCRA
    $SOUL
    $STEX
    SEC Filings

    View All

    Soulpower Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Soulpower Acquisition Corp. (0002025608) (Filer)

    6/1/26 5:00:32 PM ET
    $SOUL
    Publishing
    Consumer Discretionary

    Sharps Technology Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - SkyAI, Inc. (0001737995) (Filer)

    6/1/26 8:15:14 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - SkyAI, Inc. (0001737995) (Filer)

    5/29/26 4:30:19 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $EMIS
    $NCRA
    $SOUL
    $STEX
    Leadership Updates

    Live Leadership Updates

    View All

    Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

    WINTER PARK, Fla., May 26, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the appointment of Kori Handy as Vice President of Product and Design. Kori brings 18 years of experience scaling fintech and SaaS platforms from zero to $2B+ in assets under management and more than 200 million users, and joins Streamex at a pivotal moment in the Company's growth trajectory. Highlights Kori brings nearly two decades of product, design, and startup leadership experience building fintech and SaaS platforms used by more than 200 million p

    5/26/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer

    WINTER PARK, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the appointment of Christine Plummer, former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer of Streamex. In this role, Ms. Plummer is expected to oversee the Company's global finance organization, including financial reporting, regulatory compliance, and financial operations as Streamex continues expanding its institutional platform and launching tokenized commodity products. Henry McPhie, Co-Founder & CEO of Str

    3/16/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors

    WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of global investment, trading, and executive leadership experience to support Streamex's strategic growth, capital markets initiatives, and governance. He is joining as an independent director. Morgan Lekstrom, Co-Founder & Executive Chairman of Streamex sa

    3/3/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $EMIS
    $NCRA
    $SOUL
    $STEX
    Financials

    Live finance-specific insights

    View All

    Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the third yield payment for GLDY, its gold-backed, yield-bearing tokenized security, occurred on June 18th, 2026. The distribution covers the period from May 1st through May 31st, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is curren

    6/22/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates

    WINTER PARK, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, yesterday hosted its Q1 2026 Earnings and Corporate Update Presentation, featuring remarks from Executive Chairman Morgan Lekstrom, Chief Executive Officer Henry McPhie, Chief Financial Officer Christine Plummer, and Chief Investment Officer Mitch Williams. The following is a summary of the key topics covered. Highlights Equity Trust - access to $72B+ and 359,000 U.S. tax-advantaged retirement accounts. An upcoming integration with Equity Trust Company opens GLDY to a distribution channel that prev

    5/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces April 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., May 18, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, today announced the distribution of the second yield payment for GLDY, its gold-backed, yield-bearing tokenized security. The distribution covers the period from April 1st through April 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Gold on lease is currently earning an annualized lease yield of 3.5%. For the mo

    5/18/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $EMIS
    $NCRA
    $SOUL
    $STEX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    11/13/24 4:50:17 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    10/9/24 9:01:14 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Sharps Technology Inc.

    SC 13G - Sharps Technology Inc. (0001737995) (Subject)

    2/14/24 11:14:11 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care